VVOS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vivos Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.146 USD -2.01% Market Closed

Market Cap: $4.7m

	Vivos Therapeutics Inc NASDAQ:VVOS	US
	AVG Logistics Ltd NSE:AVG	IN
	IRCE SpA MIL:IRC	IT

Profitability Summary

Vivos Therapeutics Inc's profitability score is 17/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

62%

Strong 3Y Average Gross Margin

60%

Gross Margin is Increasing

60% > 62%

Negative Operating Margin

-108%

Negative 3Y Average Operating Margin

-103%

Operating Margin is Increasing

-136% > -108%

Negative Net Margin

-122%

Negative 3Y Average Net Margin

-101%

Declining Net Margin

-121% > -122%

Negative Free Cash Flow Margin

-91%

Negative 3Y Average Free Cash Flow Margin

-93%

Free Cash Flow Margin is Increasing

-104% > -91%

Negative ROE

-6 629%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-159%

ROIC is Increasing

-222% > -115%

View All

Hide

Collapse

17 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.